Ashton Thomas Private Wealth, LLC Nautilus Biotechnology, Inc. Transaction History
Ashton Thomas Private Wealth, LLC
- $3.86 Trillion
- Q3 2025
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 45,000 shares of NAUT stock, worth $63,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,000Holding current value
$63,900% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NAUT
# of Institutions
74Shares Held
62.8MCall Options Held
158KPut Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$23.1 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$17.9 Million0.4% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$10.2 Million0.26% of portfolio
-
Madrona Venture Group, LLC6.02MShares$8.55 Million36.76% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$5.44 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $177M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...